Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 1
1976 2
1978 1
1979 1
1980 2
1981 3
1982 1
1983 2
1984 4
1985 3
1986 4
1987 1
1988 1
1989 1
1990 1
1991 2
1992 1
1993 4
1994 2
1995 3
1996 3
1997 3
1998 7
1999 7
2000 10
2001 8
2002 11
2003 11
2004 7
2005 8
2006 9
2007 5
2008 6
2009 9
2010 6
2011 9
2012 7
2013 15
2014 19
2015 10
2016 11
2017 19
2018 22
2019 19
2020 28
2021 18
2022 18
2023 18
2024 20
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Results by year

Filters applied: . Clear all
Page 1
ACOG Practice Bulletin No. 189: Nausea And Vomiting Of Pregnancy.
Committee on Practice Bulletins-Obstetrics. Committee on Practice Bulletins-Obstetrics. Obstet Gynecol. 2018 Jan;131(1):e15-e30. doi: 10.1097/AOG.0000000000002456. Obstet Gynecol. 2018. PMID: 29266076 Review.
Furthermore, some women do not seek treatment because of concerns about the safety of medications (3). Once nausea and vomiting of pregnancy progresses, it can become more difficult to control symptoms. ...Nausea and vomiting of …
Furthermore, some women do not seek treatment because of concerns about the safety of medications (3). Once nausea and …
Nausea and vomiting of pregnancy and hyperemesis gravidarum.
Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, Painter RC, Mullin PM. Fejzo MS, et al. Nat Rev Dis Primers. 2019 Sep 12;5(1):62. doi: 10.1038/s41572-019-0110-3. Nat Rev Dis Primers. 2019. PMID: 31515515 Review.
Nausea and vomiting of pregnancy (NVP) is a common condition that affects as many as 70% of pregnant women. ...The majority of women with NVP can be managed with dietary and lifestyle changes, but more than one-third of patients experience clinically relevant
Nausea and vomiting of pregnancy (NVP) is a common condition that affects as many as 70% of pregnant women. ...The majo
The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).
Nelson-Piercy C, Dean C, Shehmar M, Gadsby R, O'Hara M, Hodson K, Nana M; Royal College of Obstetricians and Gynaecologists. Nelson-Piercy C, et al. BJOG. 2024 Jun;131(7):e1-e30. doi: 10.1111/1471-0528.17739. Epub 2024 Feb 4. BJOG. 2024. PMID: 38311315
An objective and validated index of nausea and vomiting such as the Pregnancy-Unique Quantification of Emesis (PUQE) and HyperEmesis Level Prediction (HELP) tools can be used to classify the severity of NVP and HG. ...[Grade D] All therapeutic measures should …
An objective and validated index of nausea and vomiting such as the Pregnancy-Unique Quantification of Emesis (PUQE) an …
The efficacy and safety of complementary and alternative medicine in the treatment of nausea and vomiting during pregnancy: A systematic review and meta-analysis.
Tan MY, Shu SH, Liu RL, Zhao Q. Tan MY, et al. Front Public Health. 2023 Mar 9;11:1108756. doi: 10.3389/fpubh.2023.1108756. eCollection 2023. Front Public Health. 2023. PMID: 36969661 Free PMC article. Review.
BACKGROUND: Complementary and alternative medicine (CAM) therapies are widely used for nausea and vomiting during pregnancy (NVP) due to the limitations of conventional medicine. However, their efficacy and safety remain controversial. Therefore, this …
BACKGROUND: Complementary and alternative medicine (CAM) therapies are widely used for nausea and vomiting during pregnancy
The Management of Nausea and Vomiting of Pregnancy.
Campbell K, Rowe H, Azzam H, Lane CA. Campbell K, et al. J Obstet Gynaecol Can. 2016 Dec;38(12):1127-1137. doi: 10.1016/j.jogc.2016.08.009. J Obstet Gynaecol Can. 2016. PMID: 27986189
OBJECTIVES: To review the evidence-based management of nausea and vomiting of pregnancy and hyperemesis gravidarum. EVIDENCE: MEDLINE and Cochrane database searches were performed using the medical subject headings of treatment, nausea, vomit
OBJECTIVES: To review the evidence-based management of nausea and vomiting of pregnancy and hyperemesis gravidarum. EVI …
Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 2 Factorial Trial.
Wu XK, Gao JS, Ma HL, Wang Y, Zhang B, Liu ZL, Li J, Cong J, Qin HC, Yang XM, Wu Q, Chen XY, Lu ZL, Feng YH, Qi X, Wang YX, Yu L, Cui YM, An CM, Zhou LL, Hu YH, Li L, Cao YJ, Yan Y, Liu L, Liu YX, Liu ZS, Painter RC, Ng EHY, Liu JP, Mol BWJ, Wang CC. Wu XK, et al. Ann Intern Med. 2023 Jul;176(7):922-933. doi: 10.7326/M22-2974. Epub 2023 Jun 20. Ann Intern Med. 2023. PMID: 37335994 Clinical Trial.
BACKGROUND: An effective and safe treatment for nausea and vomiting of pregnancy (NVP) is lacking. OBJECTIVE: To assess the efficacy and safety of acupuncture, doxylamine-pyridoxine, and a combination of both in women with moderate to severe NVP. ...ME …
BACKGROUND: An effective and safe treatment for nausea and vomiting of pregnancy (NVP) is lacking. OBJECTIVE: To assess …
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
In DESTINY-Breast02, we aimed to compare the efficacy and safety of trastuzumab deruxtecan with treatment of physician's choice in this patient population. ...The most common treatment-emergent adverse events were nausea (293 [73%] of 404 with trastuzumab deruxtecan …
In DESTINY-Breast02, we aimed to compare the efficacy and safety of trastuzumab deruxtecan with treatment of physician's choice in th …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Sarris J, et al. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known. ...Supportive …
Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and …
Marijuana Use in Pregnancy and While Breastfeeding.
Metz TD, Borgelt LM. Metz TD, et al. Obstet Gynecol. 2018 Nov;132(5):1198-1210. doi: 10.1097/AOG.0000000000002878. Obstet Gynecol. 2018. PMID: 30234728 Free PMC article. Review.
The prevalence and perceived safety of marijuana use in pregnancy are increasing with expanding legalization. Marijuana crosses the placenta and passes into breast milk, resulting in fetal and neonatal exposure. Many women cite medical reasons for prenatal ma …
The prevalence and perceived safety of marijuana use in pregnancy are increasing with expanding legalization. Marijuana crosse …
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E. Solmi M, et al. BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348. BMJ. 2023. PMID: 37648266 Free PMC article.
From RCTs supported by high to moderate certainty, cannabis based medicines increased adverse events related to the central nervous system (equivalent odds ratio 2.84 (95% confidence interval 2.16 to 3.73)), psychological effects (3.07 (1.79 to 5.26)), and vision (3.00 (1.79 to 5 …
From RCTs supported by high to moderate certainty, cannabis based medicines increased adverse events related to the central nervous system ( …
351 results